T-cryptantigen determination affects mortality in necrotizing enterocolitis

Area of Science:

• Neonatal Medicine
• Hematology
• Immunology

Background:

• Infants with necrotizing enterocolitis (NEC) may be exposed to the Thomsen-Friedenreich cryptantigen (TCA).
• TCA exposure can lead to severe hemolytic reactions during transfusions with plasma-containing blood products.
• Screening for TCA exposure in NEC patients is advocated for transfusion safety.

Purpose of the Study:

• To evaluate the impact of screening for Thomsen-Friedenreich cryptantigen (TCA) exposure on patient management and outcomes in infants with necrotizing enterocolitis.
• To compare the incidence of hemolysis and mortality rates between NEC patients managed with and without knowledge of TCA exposure status.

Main Methods:

• A retrospective comparison of 62 infants managed with knowledge of TCA exposure status versus 66 infants not screened during comparable four-year periods.
• Assessment of hemolytic reactions and mortality rates following blood transfusions in both groups.

Main Results:

• The unscreened group showed a significantly higher incidence of hemolysis post-transfusion (42% vs. 15%, p < 0.05).
• Mortality was significantly greater in the unscreened group (18.0% vs. 4.5%, p < 0.05).
• Knowledge of TCA exposure status during management was associated with improved outcomes.

Conclusions:

• Screening for Thomsen-Friedenreich cryptantigen (TCA) exposure is crucial for managing infants with necrotizing enterocolitis.
• TCA screening aids in diagnosis, prognosis, and importantly, in patient management, leading to reduced hemolysis and mortality.
• Implementing TCA screening protocols can significantly improve outcomes for high-risk neonatal patients.